CN116115674A - Traditional Chinese medicine formula for treating proteinuria - Google Patents
Traditional Chinese medicine formula for treating proteinuria Download PDFInfo
- Publication number
- CN116115674A CN116115674A CN202310102061.8A CN202310102061A CN116115674A CN 116115674 A CN116115674 A CN 116115674A CN 202310102061 A CN202310102061 A CN 202310102061A CN 116115674 A CN116115674 A CN 116115674A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- liquid
- medicine formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 82
- 201000001474 proteinuria Diseases 0.000 title claims abstract description 24
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 244000268590 Euryale ferox Species 0.000 claims abstract description 11
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 241000132012 Atractylodes Species 0.000 claims abstract description 7
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 7
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 7
- 241000545744 Hirudinea Species 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 7
- 235000008397 ginger Nutrition 0.000 claims abstract description 7
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000050051 Chelone glabra Species 0.000 claims abstract description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 3
- 244000247747 Coptis groenlandica Species 0.000 claims abstract 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims description 56
- 238000010438 heat treatment Methods 0.000 claims description 54
- 239000000463 material Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 18
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 238000005360 mashing Methods 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 4
- 241000037740 Coptis chinensis Species 0.000 claims description 4
- 241000237903 Hirudo Species 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 244000197580 Poria cocos Species 0.000 claims description 4
- 235000008599 Poria cocos Nutrition 0.000 claims description 4
- 240000004980 Rheum officinale Species 0.000 claims description 4
- 235000008081 Rheum officinale Nutrition 0.000 claims description 4
- 235000006533 astragalus Nutrition 0.000 claims description 4
- 235000017803 cinnamon Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 239000010419 fine particle Substances 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 235000011477 liquorice Nutrition 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 241001573366 Astragalus membranaceus Species 0.000 claims 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 241000045403 Astragalus propinquus Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010061989 glomerulosclerosis Diseases 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000017605 Hodgkin disease nodular sclerosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023421 Kidney fibrosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000008721 basement membrane thickening Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the technical field of proteinuria and discloses a traditional Chinese medicine formula for treating proteinuria, which comprises the following raw materials in parts by mass: 15-20 parts of baical skullcap root, 20-25 parts of coptis root, 20-30 parts of Indian buead, 20-25 parts of cassia bark, 30-35 parts of astragalus root, 10-15 parts of leech, 15-25 parts of black cis tablet, 10-12 parts of rhubarb, 20-22 parts of largehead atractylodes rhizome, 15-18 parts of gordon euryale seed, 18-25 parts of dried ginger, 20-30 parts of honey-fried licorice root, 25-30 parts of liquorice root and 30-35 parts of Chinese yam.
Description
Technical Field
The invention belongs to the technical field of proteinuria, and particularly relates to a traditional Chinese medicine formula for treating proteinuria.
Background
Clinical medicine shows that proteinuria is closely related to diabetes mellitus, and the proteinuria is a phenomenon of diabetes mellitus, clinically manifested by albuminuria, edema, hypertension, renal insufficiency and the like, and pathologically manifested by glomerular basement membrane thickening and extracellular matrix accumulation mainly in mesangial regions, often accompanied by renal vascular and tubular interstitial lesions, and finally caused glomerulosclerosis and renal interstitial fibrosis. The pathological manifestations are closely related to the disease progress of diabetic kidney disease;
the traditional Chinese medicine considers that proteinuria is caused by diabetes mellitus which is not healed for a long time, so that sugar toxin is diffused, and various pathological products are mixed at the same time, kidney collaterals are damaged, and kidney collaterals are formed, so that diabetes mellitus and kidney diseases are caused.
On one hand, the sugar toxin affects the vital qi and viscera functions of a human body, and at the beginning, qi is damaged, yin is consumed, and yin is damaged for a long time, so that deficiency of both qi, blood, yin and yang is caused; on the other hand, the direct injury of sugar toxin to kidney collaterals is followed by cementing and accumulating kidney collaterals by pathological products (such as qi stagnation, heat stagnation, phlegm dampness, blood stasis and the like) to form kidney collaterals abdominal mass; early kidney pathogenesis features such as distention of collaterals, swelling of collaterals, qi stagnation and heat stagnation, and increased kidney volume and glomerular filtration rate corresponding to clinical manifestations; the kidney disease in the middle stage is characterized by obstruction of collaterals, mainly phlegm dampness, water dampness or damp-heat, blood stasis, proteinuria and edema, and kidney pathology is hyperplasia of mesangial matrix, thickening of basal lamina, nodular sclerosis and the like; late kidney pathogenesis is characterized by accumulation of collaterals and collaterals, which form abdominal mass, mainly due to decline of kidney-qi and accumulation of turbid toxin, and kidney pathology is glomerulosclerosis and renal interstitial tubular fibrosis.
However, in the current market, western medicine treatment is mostly adopted for relieving proteinuria, and the problems of the kidneys of the body cannot be essentially solved, so that the effects of the western medicine are poor, and meanwhile, the western medicine can generate larger side effects to cause medicine accumulation, so that the kidney is damaged by the medicine.
Disclosure of Invention
In view of the above, in order to overcome the defects of the prior art, the invention provides a novel traditional Chinese medicine formula for treating proteinuria, which can directly act on kidneys through traditional Chinese medicines, and effectively solves the problem that western medicines cannot be used for essentially solving the problems of kidneys.
The invention is realized by the following technical scheme:
a traditional Chinese medicine formula for treating proteinuria effectively solves the problems in the background technology.
In order to achieve the above purpose, the present invention provides the following technical solutions: a traditional Chinese medicine formula for treating proteinuria comprises the following raw materials in parts by mass: 15-20 parts of radix scutellariae, 20-25 parts of coptis chinensis, 20-30 parts of poria cocos, 20-25 parts of cinnamon, 30-35 parts of astragalus membranaceus, 10-15 parts of leech, 15-25 parts of black cis tablet, 10-12 parts of rheum officinale, 20-22 parts of bighead atractylodes rhizome, 15-18 parts of semen euryales, 18-25 parts of dried ginger, 20-30 parts of honey-fried licorice root, 25-30 parts of liquorice and 30-35 parts of Chinese yam.
Preferably, the preparation of the traditional Chinese medicine formula comprises the following steps:
s1, preparing medicinal powder: putting radix Scutellariae, rhizoma Coptidis, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix Et rhizoma Rhei, rhizoma Atractylodis Macrocephalae, semen euryales, rhizoma Zingiberis, radix Glycyrrhizae Preparata and radix Glycyrrhizae into a traditional Chinese medicine pulverizing device, starting the pulverizing device, pulverizing the above materials into powder, sieving, and repeatedly grinding large-particle powder to obtain fine-particle powder;
s2, dissolving medicinal materials: placing the fine granular medicinal material powder into a heating container, adding warm water into the heating container, stirring, continuously adding water, stirring, and heating the heating container until the dissolved medicinal material emits strong medicinal fragrance;
s3, slow decocting medicinal materials: covering the heating container with a cover body, and reducing the heating temperature of the heating container until the volume of the solution in the heating container becomes half of the original volume of the solution;
s4, filtering residues and collecting liquid medicine: pouring the liquid medicine into a filtering device, separating the liquid medicine from the residue by separation of the filtering device, and filling the liquid medicine into a collecting container;
s5, preparing turbid liquid: peeling fresh rhizoma Dioscoreae, mashing into paste, adding the collected medicinal liquid into mashing container, stirring until the medicinal liquid is completely mixed with rhizoma Dioscoreae slurry to form turbid liquid, adding edible gelatinizer into turbid liquid, heating, and cooling and shaping;
s6, packaging: packaging the above materials into pill, and bottling.
Preferably, in the step S2, the medicinal material is dissolved, the total mass of water added into the heating container is 5 times of the weight of the medicinal material powder, and the specific gravity of the added warm water in the total mass of water is 2:5.
Preferably, the S4 process filters the residue, collects the liquid medicine, and after separating the liquid medicine from the residue, collects the residue at the same time, and filters the liquid medicine in the residue by multiple purification.
Preferably, in the step S5, the turbid liquid is prepared, the turbid liquid is heated, the heating temperature is controlled to be 80-100 ℃, the heating time is controlled to be 15-30min, and specific problems and time are calculated according to the specific adding dosage.
Preferably, the raw materials of the traditional Chinese medicine formula comprise the following components in percentage by mass: 20 parts of baical skullcap root, 25 parts of coptis root, 30 parts of Indian buead, 22 parts of cassia bark, 30 parts of membranous milkvetch root, 12 parts of leech, 15 parts of Heishan tablet, 12 parts of rhubarb, 22 parts of largehead atractylodes rhizome, 18 parts of gorgon euryale seed, 25 parts of dried ginger, 25 parts of honey-fried licorice root, 30 parts of liquoric root and 35 parts of Chinese yam.
Compared with the prior art, the invention has the beneficial effects that:
in operation, through the mutual coordination of western medicines, after the administration of a patient, the Chinese medicine can directly act on kidney organs of the patient, so that the problem of kidney appearance is essentially solved, the efficacy of the medicine is improved, and meanwhile, the use of the Chinese medicine does not generate side effects, thereby being beneficial to the maintenance of the medicine on the kidney.
Drawings
The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate the invention and together with the embodiments of the invention, serve to explain the invention. In the drawings:
FIG. 1 is a schematic flow chart of a traditional Chinese medicine formula;
Detailed Description
The following description of the embodiments of the present invention will be made clearly and fully with reference to the accompanying drawings, in which it is evident that the embodiments described are only some, but not all embodiments of the invention; all other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In the first embodiment, as shown in fig. 1, the invention comprises a traditional Chinese medicine formula for treating proteinuria, wherein the raw materials of the traditional Chinese medicine formula comprise the following components in percentage by mass: 20 parts of radix scutellariae, 25 parts of coptis chinensis, 30 parts of poria cocos, 22 parts of cinnamon, 30 parts of astragalus mongholicus, 12 parts of leech, 15 parts of black cis tablet, 12 parts of rheum officinale, 22 parts of bighead atractylodes rhizome, 18 parts of semen euryales, 25 parts of dried ginger, 25 parts of honey-fried licorice root, 30 parts of liquorice and 35 parts of Chinese yam;
a traditional Chinese medicine formula for treating proteinuria, the preparation of the traditional Chinese medicine formula comprises the following steps:
s1, preparing medicinal powder: putting radix Scutellariae, rhizoma Coptidis, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix Et rhizoma Rhei, rhizoma Atractylodis Macrocephalae, semen euryales, rhizoma Zingiberis, radix Glycyrrhizae Preparata and radix Glycyrrhizae into a traditional Chinese medicine pulverizing device, starting the pulverizing device, pulverizing the above materials into powder, sieving, and repeatedly grinding large-particle powder to obtain fine-particle powder;
s2, dissolving medicinal materials: placing the fine granular medicinal material powder into a heating container, adding warm water into the heating container, stirring, continuously adding water, stirring, and heating the heating container until the dissolved medicinal material emits strong medicinal fragrance; s2, dissolving medicinal materials, wherein the total mass of water added into a heating container is 5 times of the weight of medicinal material powder, and the proportion of the mass of warm water added into the heating container to the total mass of water is 2:5;
s3, slow decocting medicinal materials: covering the heating container with a cover body, and reducing the heating temperature of the heating container until the volume of the solution in the heating container becomes half of the original volume of the solution;
s4, filtering residues and collecting liquid medicine: pouring the liquid medicine into a filtering device, separating the liquid medicine from the residue by separation of the filtering device, and filling the liquid medicine into a collecting container; s4, filtering the residues, collecting the liquid medicine, separating the liquid medicine from the residues, collecting the residues at the same time, and filtering the liquid medicine in the residues by adopting a mode of multiple purification;
s5, preparing turbid liquid: peeling fresh rhizoma Dioscoreae, mashing into paste, adding the collected medicinal liquid into mashing container, stirring until the medicinal liquid is completely mixed with rhizoma Dioscoreae slurry to form turbid liquid, adding edible gelatinizer into turbid liquid, heating, and cooling and shaping; s5, preparing turbid liquid, heating the turbid liquid, controlling the heating temperature to be 80-100 ℃, controlling the heating time to be 15-30min, and calculating specific problems and time according to specific added dosage;
s6, packaging: packaging the above materials into pill, and bottling.
In the second embodiment, as shown in fig. 1, the invention comprises a traditional Chinese medicine formula for treating proteinuria, wherein the raw materials of the traditional Chinese medicine formula comprise the following components in percentage by mass: 18 parts of radix scutellariae, 20 parts of coptis chinensis, 20 parts of poria cocos, 20 parts of cinnamon, 32 parts of astragalus mongholicus, 10 parts of leech, 15 parts of black cis tablet, 10 parts of rheum officinale, 20 parts of bighead atractylodes rhizome, 15 parts of semen euryales, 18 parts of dried ginger, 20 parts of honey-fried licorice root, 25 parts of liquorice and 30 parts of Chinese yam;
a traditional Chinese medicine formula for treating proteinuria, the preparation of the traditional Chinese medicine formula comprises the following steps:
s1, preparing medicinal powder: putting radix Scutellariae, rhizoma Coptidis, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix Et rhizoma Rhei, rhizoma Atractylodis Macrocephalae, semen euryales, rhizoma Zingiberis, radix Glycyrrhizae Preparata and radix Glycyrrhizae into a traditional Chinese medicine pulverizing device, starting the pulverizing device, pulverizing the above materials into powder, sieving, and repeatedly grinding large-particle powder to obtain fine-particle powder;
s2, dissolving medicinal materials: placing the fine granular medicinal material powder into a heating container, adding warm water into the heating container, stirring, continuously adding water, stirring, and heating the heating container until the dissolved medicinal material emits strong medicinal fragrance; s2, dissolving medicinal materials, wherein the total mass of water added into a heating container is 5 times of the weight of medicinal material powder, and the proportion of the mass of warm water added into the heating container to the total mass of water is 2:4;
s3, slow decocting medicinal materials: covering the heating container with a cover body, and reducing the heating temperature of the heating container until the volume of the solution in the heating container becomes half of the original volume of the solution;
s4, filtering residues and collecting liquid medicine: pouring the liquid medicine into a filtering device, separating the liquid medicine from the residue by separation of the filtering device, and filling the liquid medicine into a collecting container; s4, filtering the residues, collecting the liquid medicine, separating the liquid medicine from the residues, collecting the residues at the same time, and filtering the liquid medicine in the residues by adopting a mode of multiple purification;
s5, preparing turbid liquid: peeling fresh rhizoma Dioscoreae, mashing into paste, adding the collected medicinal liquid into mashing container, stirring until the medicinal liquid is completely mixed with rhizoma Dioscoreae slurry to form turbid liquid, adding edible gelatinizer into turbid liquid, heating, and cooling and shaping; s5, preparing turbid liquid, heating the turbid liquid, controlling the heating temperature to be 80-100 ℃, controlling the heating time to be 20min, and calculating specific problems and time according to specific added dosage;
s6, packaging: packaging the above materials into pill, and bottling.
The licorice has sweet taste and flat nature, has the effects of tonifying qi and strengthening the middle warmer, moistening lung and relieving cough, and harmonizing drug property, can regulate symptoms such as spleen deficiency and burnout, heart deficiency and palpitation, limb spasm and the like, can regulate stomach and intestine, has good intestinal tract, and is favorable for the absorption of drugs by the intestinal tract.
The Chinese yam has sweet taste and flat nature, has the effects of tonifying qi, tonifying spleen, lung, kidney and the like, can regulate the symptoms of spleen deficiency, anorexia, lung deficiency cough and asthma, internal heat diabetes and the like, can help gastrointestinal digestion, has good intestinal tract, has viscosity and can shape the medicament.
It is noted that relational terms such as first and second, and the like are used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Moreover, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A traditional Chinese medicine formula for treating proteinuria is characterized in that: the traditional Chinese medicine formula comprises the following raw materials in percentage by mass: 15-20 parts of radix scutellariae, 20-25 parts of coptis chinensis, 20-30 parts of poria cocos, 20-25 parts of cinnamon, 30-35 parts of astragalus membranaceus, 10-15 parts of leech, 15-25 parts of black cis tablet, 10-12 parts of rheum officinale, 20-22 parts of bighead atractylodes rhizome, 15-18 parts of semen euryales, 18-25 parts of dried ginger, 20-30 parts of honey-fried licorice root, 25-30 parts of liquorice and 30-35 parts of Chinese yam.
2. The traditional Chinese medicine formula for treating proteinuria according to claim 1, wherein the traditional Chinese medicine formula is characterized in that: the preparation of the traditional Chinese medicine formula comprises the following steps:
s1, preparing medicinal powder: putting radix Scutellariae, rhizoma Coptidis, poria, cortex Cinnamomi, radix astragali, hirudo, HEISAN tablet, radix Et rhizoma Rhei, rhizoma Atractylodis Macrocephalae, semen euryales, rhizoma Zingiberis, radix Glycyrrhizae Preparata and radix Glycyrrhizae into a traditional Chinese medicine pulverizing device, starting the pulverizing device, pulverizing the above materials into powder, sieving, and repeatedly grinding large-particle powder to obtain fine-particle powder;
s2, dissolving medicinal materials: placing the fine granular medicinal material powder into a heating container, adding warm water into the heating container, stirring, continuously adding water, stirring, and heating the heating container until the dissolved medicinal material emits strong medicinal fragrance;
s3, slow decocting medicinal materials: covering the heating container with a cover body, and reducing the heating temperature of the heating container until the volume of the solution in the heating container becomes half of the original volume of the solution;
s4, filtering residues and collecting liquid medicine: pouring the liquid medicine into a filtering device, separating the liquid medicine from the residue by separation of the filtering device, and filling the liquid medicine into a collecting container;
s5, preparing turbid liquid: peeling fresh rhizoma Dioscoreae, mashing into paste, adding the collected medicinal liquid into mashing container, stirring until the medicinal liquid is completely mixed with rhizoma Dioscoreae slurry to form turbid liquid, adding edible gelatinizer into turbid liquid, heating, and cooling and shaping;
s6, packaging: packaging the above materials into pill, and bottling.
3. The traditional Chinese medicine formula for treating proteinuria according to claim 1, wherein the traditional Chinese medicine formula is characterized in that: and S2, dissolving medicinal materials, wherein the total mass of water added into a heating container is 5 times of the weight of medicinal material powder, and the proportion of the mass of warm water added into the heating container to the total mass of water is 2:5.
4. The traditional Chinese medicine formula for treating proteinuria according to claim 1, wherein the traditional Chinese medicine formula is characterized in that: and S4, filtering the medicine residues, collecting the medicine liquid, separating the medicine liquid from the medicine residues, collecting the medicine residues at the same time, and filtering the medicine liquid in the medicine residues by adopting a mode of purifying for multiple times.
5. The traditional Chinese medicine formula for treating proteinuria according to claim 1, wherein the traditional Chinese medicine formula is characterized in that: and S5, preparing turbid liquid, heating the turbid liquid, controlling the heating temperature to be 80-100 ℃, controlling the heating time to be 15-30min, and calculating specific problems and time according to the specific adding dosage.
6. The traditional Chinese medicine formula for treating proteinuria according to claim 1, wherein the traditional Chinese medicine formula is characterized in that: the traditional Chinese medicine formula comprises the following raw materials in percentage by mass: 20 parts of baical skullcap root, 25 parts of coptis root, 30 parts of Indian buead, 22 parts of cassia bark, 30 parts of membranous milkvetch root, 12 parts of leech, 15 parts of Heishan tablet, 12 parts of rhubarb, 22 parts of largehead atractylodes rhizome, 18 parts of gorgon euryale seed, 25 parts of dried ginger, 25 parts of honey-fried licorice root, 30 parts of liquoric root and 35 parts of Chinese yam.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310102061.8A CN116115674A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating proteinuria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310102061.8A CN116115674A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating proteinuria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116115674A true CN116115674A (en) | 2023-05-16 |
Family
ID=86302593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310102061.8A Pending CN116115674A (en) | 2023-02-13 | 2023-02-13 | Traditional Chinese medicine formula for treating proteinuria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116115674A (en) |
-
2023
- 2023-02-13 CN CN202310102061.8A patent/CN116115674A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103479977B (en) | Novel preparation method for pinellia stomach-harmonizing Chinese patent medicine | |
| CN102940858A (en) | Edible traditional Chinese medicine composition and preparation method thereof | |
| CN101190314A (en) | Traditional Chinese medicine formula for treating acute or chronic gastritis and preparation method | |
| CN100500131C (en) | Granular powder for strengthening spleen and nourishing stomach and preparing method | |
| CN113713039A (en) | Traditional Chinese medicine composition for treating membranous nephropathy and application thereof | |
| CN103463593B (en) | Herbal tea for treating obesity | |
| CN116115674A (en) | Traditional Chinese medicine formula for treating proteinuria | |
| CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
| CN104189764A (en) | Traditional Chinese medicinal preparation for treating intervention postoperative fever | |
| CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
| CN104189453A (en) | Radix puerariae preparation for reducing blood sugar and blood fat and production method of radix puerariae preparation | |
| CN103223024A (en) | Diabetes mellitus dialectical traditional Chinese medicine prescription | |
| CN106334065A (en) | Edible and medicinal traditional Chinese medicine formula used for treating gynecological diseases and having beauty effect and production process | |
| CN103520652B (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN103877374B (en) | A kind of for Chinese medicine treating diabetes and preparation method thereof | |
| CN114632126B (en) | Traditional Chinese medicine combination medicine for treating functional constipation and preparation method and application thereof | |
| CN103142918A (en) | Chinese patent drug for treating infantile diarrhea | |
| CN114588228B (en) | Composition for treating type 2 diabetes | |
| CN109157601B (en) | Phlegm-reducing asthma-relieving ointment and preparation method thereof | |
| CN105106578A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method of traditional Chinese medicine composition | |
| CN104436095A (en) | Malt stomach-nourishing blood stasis-dispersing digestion-promoting tablet and preparation method thereof | |
| CN105213776A (en) | A kind of Chinese medicine composition for the treatment of diabetic nephropathy and preparation method thereof | |
| CN1075083A (en) | Treatment vasculitis electuary and its method for making | |
| CN114796417A (en) | Traditional Chinese medicine formula for reducing blood sugar and preparation method thereof | |
| CN114392319A (en) | Traditional Chinese medicine composition for treating early stage of diabetes and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |